Legacy Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,620
| Closed | -$293K | – | 366 |
|
|
2024
Q2 | $293K | Sell |
22,620
-2,713
| -11% | -$35.1K | 0.05% | 259 |
|
|
2024
Q1 | $352K | Buy |
25,333
+596
| +2% | +$8.28K | 0.06% | 223 |
|
|
2023
Q4 | $353K | Sell |
24,737
-812
| -3% | -$11.6K | 0.07% | 207 |
|
|
2023
Q3 | $395K | Buy |
25,549
+834
| +3% | +$12.9K | 0.08% | 169 |
|
|
2023
Q2 | $388K | Buy |
24,715
+362
| +1% | +$5.69K | 0.07% | 167 |
|
|
2023
Q1 | $401K | Buy |
24,353
+861
| +4% | +$14.2K | 0.08% | 153 |
|
|
2022
Q4 | $366K | Sell |
23,492
-6,142
| -21% | -$95.8K | 0.08% | 150 |
|
|
2022
Q3 | $384K | Buy |
29,634
+9,264
| +45% | +$120K | 0.09% | 127 |
|
|
2022
Q2 | $286K | Buy |
20,370
+17
| +0.1% | +$239 | 0.07% | 154 |
|
|
2022
Q1 | $291K | Buy |
+20,353
| New | +$291K | 0.07% | 164 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$6K | – | 806 |
|
|
2019
Q1 | $6K | Buy |
+300
| New | +$6K | ﹤0.01% | 747 |
|